As of 2026-06-21, the Relative Valuation of Jounce Therapeutics Inc (JNCE) is (13.06) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.88 USD, the upside of Jounce Therapeutics Inc based on Relative Valuation is -794.7%.
The range of the Relative Valuation is (6.37) - (14.80) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.6x - 15.3x | 14.5x |
| Forward P/E multiples | 6.6x - 17.3x | 12.5x |
| Fair Price | (6.37) - (14.80) | (13.06) |
| Upside | -438.6% - -887.3% | -794.7% |
| Date | P/E |